z-logo
open-access-imgOpen Access
Favipiravir Use in Kidney Transplant Recipients with COVID-19: A Single-Center Experience
Author(s) -
Burcu Kaya,
Dilek Barutçu Ataş,
Elif Tükenmez Tigen,
Ebru Aşıcıoğlu,
Hakkı Arıkan,
Serhan Tuğlular,
Arzu Velioğlu
Publication year - 2022
Publication title -
experimental and clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.321
H-Index - 29
ISSN - 1304-0855
DOI - 10.6002/ect.2021.0252
Subject(s) - favipiravir , medicine , adverse effect , single center , expanded access , kidney transplantation , transplantation , covid-19 , surgery , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom